Logo image of ABVX

ABIVAX SA-ADR (ABVX) Stock Overview

NASDAQ:ABVX - US00370M1036 - ADR

79.7 USD
+2.24 (+2.89%)
Last: 8/26/2025, 8:13:41 PM
81.02 USD
+1.32 (+1.66%)
Pre-Market: 8/27/2025, 7:26:25 AM

ABVX Key Statistics, Chart & Performance

Key Statistics
52 Week High80
52 Week Low4.77
Market Cap6.02B
Shares75.55M
Float70.26M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-2.72
PEN/A
Fwd PEN/A
Earnings (Next)09-08 2025-09-08
IPO06-26 2015-06-26
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


ABVX short term performance overview.The bars show the price performance of ABVX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 200 400 600 800 1K

ABVX long term performance overview.The bars show the price performance of ABVX in the last 1, 2 and 3 years. 1 year 2 years 3 years 100 200 300 400 500

The current stock price of ABVX is 79.7 USD. In the past month the price increased by 14.18%. In the past year, price increased by 527.06%.

ABIVAX SA-ADR / ABVX Daily stock chart

ABVX Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 19.68 368.08B
AMGN AMGEN INC 13.28 155.90B
GILD GILEAD SCIENCES INC 14.83 142.38B
VRTX VERTEX PHARMACEUTICALS INC 22.86 99.27B
REGN REGENERON PHARMACEUTICALS 12.88 62.29B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 59.14B
ARGX ARGENX SE - ADR 76.39 43.34B
ONC BEONE MEDICINES LTD-ADR 6.24 36.72B
INSM INSMED INC N/A 27.94B
BNTX BIONTECH SE-ADR N/A 25.19B
NTRA NATERA INC N/A 22.74B
BIIB BIOGEN INC 8.54 20.04B

About ABVX

Company Profile

ABVX logo image Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. The company is headquartered in Paris, Ile-De-France and currently employs 67 full-time employees. The company went IPO on 2015-06-26. ABIVAX utilizes RNA-protein interaction interference and cytotoxic TH1 cell amplification to generate therapies to help patients clear viruses like HIV, HBV and HPV. The firm's product pipeline comprises ABX 203, which is the therapeutic vaccine candidate obtained from the Centre for Genetic Engineering and Biotechnology, Cuba (CIGB) and is intended for patients with chronic hepatitis B disease; and ABX196, the adjuvant for therapeutic vaccines, among others.

Company Info

ABIVAX SA-ADR

7-11 Boulevard Haussmann

Paris ILE-DE-FRANCE FR

Employees: 69

ABVX Company Website

ABVX Investor Relations

Phone: 33153830963

ABIVAX SA-ADR / ABVX FAQ

What is the stock price of ABIVAX SA-ADR today?

The current stock price of ABVX is 79.7 USD. The price increased by 2.89% in the last trading session.


What is the ticker symbol for ABIVAX SA-ADR stock?

The exchange symbol of ABIVAX SA-ADR is ABVX and it is listed on the Nasdaq exchange.


On which exchange is ABVX stock listed?

ABVX stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for ABIVAX SA-ADR stock?

13 analysts have analysed ABVX and the average price target is 84.31 USD. This implies a price increase of 5.78% is expected in the next year compared to the current price of 79.7. Check the ABIVAX SA-ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ABIVAX SA-ADR worth?

ABIVAX SA-ADR (ABVX) has a market capitalization of 6.02B USD. This makes ABVX a Mid Cap stock.


How many employees does ABIVAX SA-ADR have?

ABIVAX SA-ADR (ABVX) currently has 69 employees.


What are the support and resistance levels for ABIVAX SA-ADR (ABVX) stock?

ABIVAX SA-ADR (ABVX) has a support level at 76.64. Check the full technical report for a detailed analysis of ABVX support and resistance levels.


Is ABIVAX SA-ADR (ABVX) expected to grow?

The Revenue of ABIVAX SA-ADR (ABVX) is expected to grow by 124.58% in the next year. Check the estimates tab for more information on the ABVX EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ABIVAX SA-ADR (ABVX) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ABIVAX SA-ADR (ABVX) stock pay dividends?

ABVX does not pay a dividend.


When does ABIVAX SA-ADR (ABVX) report earnings?

ABIVAX SA-ADR (ABVX) will report earnings on 2025-09-08.


What is the Price/Earnings (PE) ratio of ABIVAX SA-ADR (ABVX)?

ABIVAX SA-ADR (ABVX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.72).


What is the Short Interest ratio of ABIVAX SA-ADR (ABVX) stock?

The outstanding short interest for ABIVAX SA-ADR (ABVX) is 2.63% of its float. Check the ownership tab for more information on the ABVX short interest.


ABVX Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to ABVX. When comparing the yearly performance of all stocks, ABVX is one of the better performing stocks in the market, outperforming 99.87% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ABVX Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to ABVX. ABVX may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ABVX Financial Highlights

Over the last trailing twelve months ABVX reported a non-GAAP Earnings per Share(EPS) of -2.72. The EPS increased by 16.74% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -85.88%
ROE -434.26%
Debt/Equity 1.29
Chartmill High Growth Momentum
EPS Q2Q%21.47%
Sales Q2Q%N/A
EPS 1Y (TTM)16.74%
Revenue 1Y (TTM)N/A

ABVX Forecast & Estimates

13 analysts have analysed ABVX and the average price target is 84.31 USD. This implies a price increase of 5.78% is expected in the next year compared to the current price of 79.7.

For the next year, analysts expect an EPS growth of 3.43% and a revenue growth 124.58% for ABVX


Analysts
Analysts87.69
Price Target84.31 (5.78%)
EPS Next Y3.43%
Revenue Next Year124.58%

ABVX Ownership

Ownership
Inst Owners42.26%
Ins OwnersN/A
Short Float %2.63%
Short Ratio1.19